Is iron replacement indicated for a patient with serum iron 26 µg/dL, transferrin saturation 9 %, ferritin 150 ng/mL, and hemoglobin 9.4 g/dL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, iron replacement is strongly indicated in this patient.

With a transferrin saturation of only 9% and hemoglobin of 9.4 g/dL, this patient has clear functional iron deficiency requiring iron replacement, despite the ferritin level of 150 ng/mL.

Key Diagnostic Findings

Your patient demonstrates:

  • Transferrin saturation 9% - severely low (normal >20%)
  • Hemoglobin 9.4 g/dL - anemia
  • Ferritin 150 ng/mL - appears adequate but misleading in this context

Why Iron Replacement is Indicated

The transferrin saturation of 9% is the critical finding here. This indicates functional iron deficiency - meaning insufficient iron is available for erythropoiesis despite seemingly adequate ferritin stores 1.

Understanding the Ferritin Paradox

Ferritin can be elevated as an acute-phase reactant in inflammatory conditions, potentially masking true iron deficiency 2. A ferritin of 150 ng/mL does NOT exclude iron deficiency when transferrin saturation is this low. In fact:

  • British Society of Gastroenterology guidelines define absolute iron deficiency as transferrin saturation ≤20% 1
  • Your patient's TSAT of 9% is well below this threshold
  • The combination of low TSAT with anemia (Hb 9.4) strongly predicts response to iron therapy

Evidence Supporting Treatment

Research in hemodialysis patients (which provides useful insights into iron metabolism) shows that:

  • Transferrin saturation <20% with ferritin <150 ng/mL indicates inadequate iron for erythropoiesis 3
  • Serum iron levels correlate with hemoglobin response to iron supplementation 4
  • The optimal iron status includes transferrin saturation ≥20% 5

Treatment Approach

Route of administration depends on underlying condition:

Consider Intravenous Iron if:

  • Chronic kidney disease (especially if on dialysis) 1
  • Chronic heart failure - IV iron has prognostic benefit; oral iron should be avoided 1
  • Inflammatory bowel disease with moderate-severe anemia (Hb <10 g/dL) 1
  • Intolerance to oral iron
  • Malabsorption suspected

Oral Iron May Be Appropriate if:

  • No contraindications listed above
  • Patient can tolerate it
  • No evidence of malabsorption
  • Not on dialysis

Critical Pitfalls to Avoid

  1. Don't be falsely reassured by ferritin of 150 ng/mL - the TSAT of 9% overrides this finding
  2. Don't delay treatment - the patient is already anemic (Hb 9.4)
  3. Investigate the underlying cause - this degree of iron deficiency warrants evaluation for:
    • GI blood loss (consider endoscopy if absolute iron deficiency)
    • Malabsorption
    • Chronic inflammatory conditions
    • Chronic kidney disease
    • Menstrual losses (if applicable)

Monitoring After Treatment

Recheck iron studies and hemoglobin in 4-8 weeks to assess response. Target transferrin saturation >20% and hemoglobin normalization 1, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.